- SG$25.48m
- SG$22.43m
- SG$12.59m
- 98
- 66
- 57
- 90
Annual income statement for Medinex, fiscal year end - March 31st, SGD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 15 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16.7 | 10.8 | 12 | 13 | 12.6 |
Cost of Revenue | |||||
Gross Profit | 11.8 | 7.66 | 8.57 | 9.48 | 9.68 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.2 | 8.15 | 9.5 | 10.9 | 11.7 |
Operating Profit | 4.53 | 2.63 | 2.5 | 2.03 | 0.897 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 4.65 | 3.86 | 3.27 | 2.04 | 1.02 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.09 | 3.55 | 2.9 | 1.69 | 0.867 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.64 | 3.49 | 2.81 | 1.7 | 1.03 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.64 | 3.49 | 2.81 | 1.7 | 1.03 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.028 | 0.022 | 0.024 | 0.013 | 0.015 |
Dividends per Share |